Holding CoVID in check through JAK? The MPN-approved compound ruxolitinib as a potential strategy to treat SARS-CoV-2 induced systemic hyperinflammation.

Heidel, F; Hochhaus, A

Heidel, F; Hochhaus, A.

Heidel F; Klinik für Innere Medizin II, Universitätsklinikum, Jena, Germany. florian.heidel@med.uni-jena.de.
Hochhaus A; Klinik für Innere Medizin II, Universitätsklinikum, Jena, Germany.

Leukemia ; 34(7): 1723-1725, 2020 07.

Article in English | MEDLINE | ID: covidwho-595619

Subject(s)

Coronavirus Infections; Pandemics; Pneumonia, Viral; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; COVID-19; Humans; Janus Kinase 1; Nitriles; Pyrazoles; Pyrimidines; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Severe acute respiratory syndrome-related coronavirus / Pandemics Limits: Humans Language: English Journal: Leukemia Journal subject: Hematology / Neoplasms Year: 2020 Document Type: Article Affiliation country: S41375-020-0898-6

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google